ArticleBritish journal of pharmacology2018

A long-acting FGF21 alleviates hepatic steatosis and inflammation in a mouse model of non-alcoholic steatohepatitis partly through an FGF21-adiponectin-IL17A pathway.

Lichen Bao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.